Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, the discussions reflect a moderate level of support and curiosity, with references to both the antioxidant effects of isoliquiritigenin and the novel involvement of circRNA in glioma, evidenced by phrases like 'shows potential' and questions about the ISL-circRNA relationship. The tone combines cautious optimism with scientific curiosity, contributing to a balanced view of its potential impact.
Most discussions acknowledge the potential of isoliquiritigenin in glioma treatment, indicating general agreement with the research's significance.
Participants show moderate interest, often referencing the antioxidative and antitumor properties but expressing curiosity about the specific mechanisms.
Comments include mention of research details, such as the role of circ0030018 and the miR-1236/HER2 pathway, suggesting active engagement.
The discussions recognize the potential for this research to impact future therapeutic strategies for glioma, highlighting its relevance.
In #glioma, isoliquiritigenin (ISL) shows antioxidative and antitumor activities but ISL-circRNA relationship is not known. Researchers studied
RT @cancerscnews: In #glioma, isoliquiritigenin (ISL) shows antioxidative and antitumor activities but ISL-circRNA relationship is not know…
Isoliquiritigenin has potential antitumor effects by downregulating circ0030018 in glioma cells, reducing growth and invasion, and acting through the miR-1236/HER2 pathway, highlighting a promising therapeutic target.
RT @cancerscnews: In #glioma, isoliquiritigenin (ISL) shows antioxidative and antitumor activities but ISL-circRNA relationship is not know…
In #glioma, isoliquiritigenin (ISL) shows antioxidative and antitumor activities but ISL-circRNA relationship is not known. Researchers studied